Skip to main content
CriticalFDAfda-F-0574-2020UNDECLARED ALLERGEN

Jeni's Dairy Free Cold Brew with Coconut Cream Pints frozen dessert

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
49,358
Recall Date
January 3, 2020
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0574-2020.

May contain undeclared milk allergen

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0574-2020.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Jeni's Splendid Ice Creams Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0574-2020.

Jeni's Splendid Ice Creams LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Jeni's Splendid Ice Creams Llc Recall FAQ

Jeni's Splendid Ice Creams Llc is the subject of a dairy safety report: Jeni's Dairy Free Cold Brew with Coconut Cream Pints frozen dessert. The notice was published on January 3, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 49,358 units are potentially affected.